A recent mouse model study emphasized the adaptability of colon cancer signaling suggesting increased ERK5 kinase phosphorylation to compensate for an abrogation of ERK1/2 activation in colon tumorigenesis in maintaining cell proliferation [22]. Here, MAPK3 is linked to malignant colon neoplasm.